RT Journal Article
SR Electronic
T1 State-Level Gestational Diabetes Prevalence Estimates from Three Data Sources, 2018
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.30.23297796
DO 10.1101/2023.10.30.23297796
A1 Bolduc, Michele L.F.
A1 Mercado, Carla I.
A1 Zhang, Yan
A1 Lundeen, Elizabeth A.
A1 Ford, Nicole D.
A1 Bullard, Kai McKeever
A1 Carty, Denise C.
YR 2023
UL http://medrxiv.org/content/early/2023/10/31/2023.10.30.23297796.abstract
AB We investigated 2018 gestational diabetes mellitus (GDM) prevalence estimates in three surveillance systems (National Vital Statistics System, State Inpatient Database, and Pregnancy Risk Assessment Monitoring Survey). We calculated state GDM prevalence for each system; a subset of data was analyzed for women 18-39 years old in 22 locations present in all three systems to observe dataset-specific demographics and GDM prevalence using comparable categories. GDM prevalence estimates varied widely by data system and within the data subset despite comparable demographics. Understanding the differences between GDM surveillance data systems can help researchers better identify people and places at higher risk of GDM.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur work received no grant funding or separate financial support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNVSS data used for this project are publicly available via CDC Wonder (https://wonder.cdc.gov/natality.html). Access to HCUP and PRAMS datasets must be formally requested by researchers. https://wonder.cdc.gov/natality.html https://hcup-us.ahrq.gov/db/state/siddbdocumentation.jsp https://www.cdc.gov/prams/prams-data/researchers.htm